Detalhe da pesquisa
1.
Boosting with variant-matched or historical mRNA vaccines protects against Omicron infection in mice.
Cell
; 185(9): 1572-1587.e11, 2022 04 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-35452622
2.
Mucosal vaccine-induced cross-reactive CD8+ T cells protect against SARS-CoV-2 XBB.1.5 respiratory tract infection.
Nat Immunol
; 25(3): 537-551, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38337035
3.
Author Correction: Mucosal vaccine-induced cross-reactive CD8+ T cells protect against SARS-CoV-2 XBB.1.5 respiratory tract infection.
Nat Immunol
; 25(3): 578, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38360936
4.
Avian influenza A viruses exhibit plasticity in sialylglycoconjugate receptor usage in human lung cells.
J Virol
; 97(11): e0090623, 2023 Nov 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-37843369
5.
Host factor Rab11a is critical for efficient assembly of influenza A virus genomic segments.
PLoS Pathog
; 17(5): e1009517, 2021 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33970958
6.
The p150 Isoform of ADAR1 Blocks Sustained RLR signaling and Apoptosis during Influenza Virus Infection.
PLoS Pathog
; 16(9): e1008842, 2020 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32898178
7.
Intestinal helminth infection impairs vaccine-induced T cell responses and protection against SARS-CoV-2.
bioRxiv
; 2024 Jan 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-38293221
8.
Immunoglobulin replacement products protect against SARS-CoV-2 infection in vivo despite poor neutralizing activity.
JCI Insight
; 9(3)2024 Feb 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-38175703
9.
A bivalent ChAd nasal vaccine protects against SARS-CoV-2 BQ.1.1 and XBB.1.5 infection and disease in mice and hamsters.
bioRxiv
; 2023 May 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-37205450
10.
Bivalent SARS-CoV-2 mRNA vaccines increase breadth of neutralization and protect against the BA.5 Omicron variant in mice.
Nat Med
; 29(1): 247-257, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36265510
11.
mRNA-1273 and Ad26.COV2.S vaccines protect against the B.1.621 variant of SARS-CoV-2.
Med
; 3(5): 309-324.e6, 2022 05 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-35584653
12.
Protective activity of mRNA vaccines against ancestral and variant SARS-CoV-2 strains.
Sci Transl Med
; 14(630): eabm3302, 2022 Feb 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34846168
13.
Boosting with Omicron-matched or historical mRNA vaccines increases neutralizing antibody responses and protection against B.1.1.529 infection in mice.
bioRxiv
; 2022 Feb 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35169795
14.
mRNA vaccine boosting enhances antibody responses against SARS-CoV-2 Omicron variant in individuals with antibody deficiency syndromes.
Cell Rep Med
; 3(6): 100653, 2022 06 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-35688161
15.
SARS-CoV-2 booster vaccination rescues attenuated IgG1 memory B cell response in primary antibody deficiency patients.
Front Immunol
; 13: 1033770, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36618402
16.
Robust induction of TRMs by combinatorial nanoshells confers cross-strain sterilizing immunity against lethal influenza viruses.
Mol Ther Methods Clin Dev
; 21: 299-314, 2021 Jun 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-33898629
17.
Protective activity of mRNA vaccines against ancestral and variant SARS-CoV-2 strains.
bioRxiv
; 2021 Aug 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-34462745
18.
Vaccine-induced antigen-specific regulatory T cells attenuate the antiviral immunity against acute influenza virus infection.
Mucosal Immunol
; 11(4): 1239-1253, 2018 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-29467445